KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Amortizatization of Intangibles (2016 - 2025)

West Pharmaceutical Services' Amortizatization of Intangibles history spans 17 years, with the latest figure at $600000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 33.33% year-over-year to $600000.0; the TTM value through Dec 2025 reached $2.8 million, down 22.22%, while the annual FY2025 figure was $2.8 million, 22.22% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $600000.0 at West Pharmaceutical Services, down from $700000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.1 million in Q4 2021 and bottomed at $500000.0 in Q2 2023.
  • The 5-year median for Amortizatization of Intangibles is $900000.0 (2022), against an average of $955000.0.
  • The largest annual shift saw Amortizatization of Intangibles soared 90.91% in 2021 before it crashed 52.38% in 2022.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $2.1 million in 2021, then plummeted by 52.38% to $1.0 million in 2022, then grew by 30.0% to $1.3 million in 2023, then crashed by 30.77% to $900000.0 in 2024, then tumbled by 33.33% to $600000.0 in 2025.
  • Per Business Quant, the three most recent readings for WST's Amortizatization of Intangibles are $600000.0 (Q4 2025), $700000.0 (Q3 2025), and $600000.0 (Q2 2025).